Skip to main content
A Singapore Government Agency Website How to identify
Official website links end with .gov.sg
Secure websites use HTTPS
Look for a lock () or https:// as an added precaution. Share sensitive information only on official, secure websites.
Government officials will never ask you to transfer money or disclose bank log-in details over a phone call.

Call the 24/7 ScamShield Helpline at 1799 if you are unsure if something is a scam.

National Drug Formulary

CAVSAMIR FILM COATED TABLET 800MG [SIN16993P]

Active ingredients: SEVELAMER CARBONATE

View product's general information
Last updated on 9 October 2026

Product Info

CAVSAMIR FILM COATED TABLET 800MG

[SIN16993P]

Product information

Active Ingredient and Strength

SEVELAMER CARBONATE - 800 MG

Dosage Form

TABLET, FILM COATED

Manufacturer and Country

DR. REDDY'S LABORATORIES LIMITED - INDIA

Registration Number

SIN16993P

Licence Holder

EURO ASIA MEDICO PTE. LTD.

Forensic Classification

PRESCRIPTION ONLY MEDICINES

Anatomical Therapeutic Chemical (ATC) code

V03AE02

Prescription-only Medicines with Exemptions for Supply without Prescription

NA

Indication

1 INDICATIONS AND USAGE
Sevelamer Carbonate is indicated for the control of hyperphosphatemia in adult patients receiving haemodialysis or peritoneal dialysis.
Sevelamer Carbonate is also indicated for the control of hyperphosphataemia in adult patients with chronic kidney disease not on dialysis with serum phosphorus ≥ 1.78 mmol/l.
Sevelamer Carbonate should be used within the context of a multiple therapeutic approach, which could include calcium supplement, 1,25-dihydroxyvitamin D3 or one of its analogues to control the development of renal bone disease.

Dosing

2 DOSAGE AND ADMINISTRATION
Due to the rapid reaction of the drug with hydrochloric acid in stomach, the dosage of Sevelamer Carbonate tablet is expected to be similar with hydrochloride.

2.1 General Dosing Information
The drug should be taken 3 times daily with meals.
Dose for Adult Patients Not Taking a Phosphate Binder: The recommended starting dose of Sevelamer Carbonate is 0.8 to 1.6 g with meals based on serum phosphorus level. Table 1 provides recommended starting doses of Sevelamer Carbonate for adult patients not taking a phosphate binder.

Cavsamir Dosage Table 1



Switching from Sevelamer Hydrochloride Tablets: For adult patients switching from Sevelamer Hydrochloride tablets to Sevelamer Carbonate tablets or powder, use the same dose in grams. To achieve the target phosphate concentration, further adjusting of dose may be necessary. For CKD patients on dialysis treatment, the highest daily dose of the used Sevelamer Carbonate in the study is 14 grams.

Switching from Calcium Acetate: A research performing on 84 of CKD patients on dialysis indicated that equivalent dose (approximate mg to mg) of Sevelamer Hydrochloride and Calcium Acetate showed similar decreasing serum phosphorus levels. Table 2 gives recommended starting doses of Sevelamer Carbonate based on a patient's current calcium acetate dose.

Cavsamir Dosage Table 2



Adjusting doses for all patients using this product: The dose should be increased or decreased by one tablet per meal at two week intervals, as necessary, with the goal of controlling serum phosphorus within the target range of 3.5 mg/dL to 5.5 mg/dL.
Sevelamer Carbonate tablet should be swallowed entirely and should not be grinded, chewed to fragments or split.

Contraindications

4. CONTRAINDICATIONS
Sevelamer carbonate is contraindicated in patients with hypophosphatemia and bowel obstruction.
Sevelamer carbonate is contraindicated in patients with known hypersensitivity to sevelamer carbonate, or to any of the excipients.